Literature DB >> 23563877

Headaches during pregnancy.

Kathleen B Digre1.   

Abstract

Headache is a common symptom in pregnant women. Although most headaches seen in women are primary headache disorders (migraine, tension-type headache), complications or conditions associated with pregnancy can present with a secondary headache. Headaches are common symptoms in idiopathic intracranial hypertension, eclampsia, and reversible cerebral vascular syndrome. Migraines may begin or worsen during pregnancy, but pregnancy tends to reduce migraine frequency and severity. Although it is desirable to avoid medications for headaches during pregnancy, treatment should be considered when headaches are severe and cause significant disability. Being aware of possible treatments for migraine and headaches during pregnancy is essential.

Entities:  

Mesh:

Year:  2013        PMID: 23563877     DOI: 10.1097/GRF.0b013e31828f25e6

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  4 in total

Review 1.  Migraine in pregnancy and lactation.

Authors:  Paru S David; Juliana M Kling; Amaal J Starling
Journal:  Curr Neurol Neurosci Rep       Date:  2014-04       Impact factor: 5.081

Review 2.  Managing Migraine During Pregnancy and Lactation.

Authors:  Rebecca Erwin Wells; Dana P Turner; Michelle Lee; Laura Bishop; Lauren Strauss
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

3.  Clinical and Radiologic Disease Activity in Pregnancy and Postpartum in MS.

Authors:  Annika Anderson; Kristen M Krysko; Alice Rutatangwa; Tanya Krishnakumar; Chelsea Chen; William Rowles; Chao Zhao; Maria K Houtchens; Riley Bove
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-02-19

4.  Characteristics of menstrual versus non-menstrual migraine during pregnancy: a longitudinal population-based study.

Authors:  Beáta Éva Petrovski; Kjersti G Vetvik; Christofer Lundqvist; Malin Eberhard-Gran
Journal:  J Headache Pain       Date:  2018-04-02       Impact factor: 7.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.